US3977555A
(en)
|
1974-05-07 |
1976-08-31 |
Pharmaco, Inc. |
Protective safety cap for medicament vial
|
US4176756A
(en)
*
|
1977-06-27 |
1979-12-04 |
Becton, Dickinson And Company |
Stopper lock for culture bottle
|
US4405161A
(en)
*
|
1981-06-09 |
1983-09-20 |
A. Steven Young |
Wellhead security apparatus
|
US4372593A
(en)
*
|
1981-06-17 |
1983-02-08 |
Kesselman David A |
Tamper indicator
|
US4471982A
(en)
*
|
1982-03-22 |
1984-09-18 |
Nielsen Jr Anker J |
Tamper indicating cover for a gas meter
|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
US4759756A
(en)
|
1984-09-14 |
1988-07-26 |
Baxter Travenol Laboratories, Inc. |
Reconstitution device
|
US4614437A
(en)
|
1984-11-02 |
1986-09-30 |
Dougherty Brothers Company |
Mixing container and adapter
|
US4675020A
(en)
|
1985-10-09 |
1987-06-23 |
Kendall Mcgaw Laboratories, Inc. |
Connector
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
US5100394A
(en)
|
1988-01-25 |
1992-03-31 |
Baxter International Inc. |
Pre-slit injection site
|
JPH021277A
(ja)
|
1988-03-31 |
1990-01-05 |
Fujisawa Pharmaceut Co Ltd |
輸液容器
|
US5195992A
(en)
|
1988-05-13 |
1993-03-23 |
Baxter International Inc. |
Protector shield for needles
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
AU646822B2
(en)
|
1989-10-13 |
1994-03-10 |
Kirin-Amgen Inc. |
Erythropoietin isoforms
|
US5171214A
(en)
|
1990-12-26 |
1992-12-15 |
Abbott Laboratories |
Drug storage and delivery system
|
WO1993010001A1
(en)
|
1991-11-21 |
1993-05-27 |
Gds Technology, Inc. |
Fluid transfer device
|
US5279576A
(en)
|
1992-05-26 |
1994-01-18 |
George Loo |
Medication vial adapter
|
US5334179A
(en)
|
1992-10-16 |
1994-08-02 |
Abbott Laboratories |
Latching piercing pin for use with fluid vials of varying sizes
|
US5250037A
(en)
|
1992-12-18 |
1993-10-05 |
Becton, Dickinson And Company |
Syringe having needle isolation features
|
JPH06239352A
(ja)
|
1993-02-05 |
1994-08-30 |
Nissho Corp |
溶解液注入セット
|
US5429614A
(en)
|
1993-06-30 |
1995-07-04 |
Baxter International Inc. |
Drug delivery system
|
US5397303A
(en)
|
1993-08-06 |
1995-03-14 |
River Medical, Inc. |
Liquid delivery device having a vial attachment or adapter incorporated therein
|
CN1057534C
(zh)
|
1993-08-17 |
2000-10-18 |
柯瑞英-艾格公司 |
促红细胞生成素类似物
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
IL114909A
(en)
|
1994-08-12 |
1999-10-28 |
Immunomedics Inc |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
US5526853A
(en)
|
1994-08-17 |
1996-06-18 |
Mcgaw, Inc. |
Pressure-activated medication transfer system
|
IL114960A0
(en)
|
1995-03-20 |
1995-12-08 |
Medimop Medical Projects Ltd |
Flow control device
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
HUP9901333A3
(en)
|
1995-07-11 |
1999-12-28 |
Nycomed Imaging As |
Piercing pin for an infusion system
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
GB9611562D0
(en)
|
1996-06-03 |
1996-08-07 |
Applied Research Systems |
Device
|
US5957898A
(en)
|
1997-05-20 |
1999-09-28 |
Baxter International Inc. |
Needleless connector
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
BR9812267B1
(pt)
|
1997-07-14 |
2013-11-26 |
|
Hormônio de crescimento recombinante.
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
US6090092A
(en)
|
1997-12-04 |
2000-07-18 |
Baxter International Inc. |
Sliding reconstitution device with seal
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
US6209738B1
(en)
|
1998-04-20 |
2001-04-03 |
Becton, Dickinson And Company |
Transfer set for vials and medical containers
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
US6548653B1
(en)
|
1998-06-15 |
2003-04-15 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
US6358236B1
(en)
|
1998-08-06 |
2002-03-19 |
Baxter International Inc. |
Device for reconstituting medicaments for injection
|
US6022339A
(en)
|
1998-09-15 |
2000-02-08 |
Baxter International Inc. |
Sliding reconstitution device for a diluent container
|
US7425209B2
(en)
|
1998-09-15 |
2008-09-16 |
Baxter International Inc. |
Sliding reconstitution device for a diluent container
|
US7074216B2
(en)
|
1998-09-15 |
2006-07-11 |
Baxter International Inc. |
Sliding reconstitution device for a diluent container
|
ES2283139T5
(es)
|
1998-10-23 |
2018-03-05 |
Amgen Inc. |
Métodos y composiciones para la prevención y tratamiento de la anemia
|
DE69934425T2
(de)
|
1998-10-23 |
2007-09-27 |
Amgen Inc., Thousand Oaks |
Thrombopoietin substitute
|
US6755810B1
(en)
|
1998-11-17 |
2004-06-29 |
Novo Nordisk A/S |
Medicament transferring device
|
NZ552959A
(en)
|
1998-11-27 |
2008-06-30 |
Darwin Discovery Ltd |
Compositions and methods for increasing bone mineralization
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
JP2002544123A
(ja)
|
1999-04-14 |
2002-12-24 |
スミスクライン・ビーチャム・コーポレイション |
エリトロポイエチン受容体抗体
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
US6319224B1
(en)
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
DE19939936A1
(de)
|
1999-08-23 |
2001-03-08 |
Beru Ag |
Einrichtung zum Überwachen und drahtlosen Signalisieren des Drucks in Luftreifen an Fahrzeugen
|
AU2154401A
(en)
|
1999-11-12 |
2001-05-30 |
Merck Patent Gmbh |
Erythropoietin forms with improved properties
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
SI1274728T1
(sl)
|
2000-04-21 |
2008-08-31 |
Amgen Inc |
Postopek in sestavki za prepreäśevanje in/ali zdravljenje anemije
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
WO2002019963A2
(en)
|
2000-09-08 |
2002-03-14 |
Gryphon Therapeutics, Inc. |
Synthetic erythropoiesis stimulating proteins
|
AU2001247060A1
(en)
*
|
2000-11-07 |
2002-05-21 |
Lozon Llc |
Splicing device and method for sealing conduit spaces
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
EP1345628B1
(en)
|
2000-12-20 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
|
CA2433800C
(en)
|
2001-01-05 |
2016-09-13 |
Pfizer Inc. |
Antibodies to insulin-like growth factor i receptor
|
US6474375B2
(en)
|
2001-02-02 |
2002-11-05 |
Baxter International Inc. |
Reconstitution device and method of use
|
US6656433B2
(en)
|
2001-03-07 |
2003-12-02 |
Churchill Medical Systems, Inc. |
Vial access device for use with various size drug vials
|
CA2443373A1
(en)
|
2001-04-04 |
2002-10-31 |
Genodyssee |
New polynucleotides and polypeptides of the erythropoietin gene
|
EE05294B1
(et)
|
2001-05-11 |
2010-04-15 |
Amgen Inc. |
TALL-1-ga seostuv ainekompositsioon
|
IL143883A0
(en)
|
2001-06-20 |
2002-04-21 |
Cyclo Fil Ltd |
Safety dispensing system and method
|
ES2674888T3
(es)
|
2001-06-26 |
2018-07-04 |
Amgen Inc. |
Anticuerpos para OPGL
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
PT1425389E
(pt)
|
2001-08-23 |
2012-02-07 |
Genmab As |
Anticorpos humanos específicos para interleucina 15 (il-15)
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
TW509024U
(en)
*
|
2001-10-12 |
2002-11-01 |
You-Tsuen Ye |
Simple portable suspension component for bottle buckle
|
EP1323403B1
(en)
|
2001-12-17 |
2006-04-19 |
Bristol-Myers Squibb Company |
Transfer device and system comprising a cap assembly, a container and the transfer device
|
WO2003055526A2
(en)
|
2001-12-21 |
2003-07-10 |
Maxygen Aps |
Erythropoietin conjugates
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
ES2427964T3
(es)
|
2002-01-18 |
2013-11-05 |
Pierre Fabre Medicament |
Nuevos anticuerpos anti-IGF-IR y sus aplicaciones
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
WO2003064664A1
(en)
|
2002-01-31 |
2003-08-07 |
Oxford Biomedica (Uk) Limited |
Physiologically regulated erythropoietin- exprressing vector for the treatment of anaemia
|
US6875205B2
(en)
|
2002-02-08 |
2005-04-05 |
Alaris Medical Systems, Inc. |
Vial adapter having a needle-free valve for use with vial closures of different sizes
|
EP1492878B1
(en)
|
2002-03-26 |
2007-05-30 |
Lek Pharmaceutical and Chemical Co. D.D. |
Process for the preparation of a desired erythropoietin glyco-isoform profile
|
EP1572079A4
(en)
|
2002-03-29 |
2006-09-06 |
Centocor Inc |
MAMMAL-CDR MIMETIC BODIES, COMPOSITIONS, PROCESSES AND APPLICATION PURPOSES
|
AU2003232122A1
(en)
|
2002-05-13 |
2003-11-11 |
Technion Entrepreneurial Incubator Company Ltd. |
Ctp-extended erythropoietin
|
CA2484000A1
(en)
|
2002-05-24 |
2003-12-04 |
Schering Corporation |
Neutralizing human anti-igfr antibody
|
US6666238B1
(en)
*
|
2002-06-13 |
2003-12-23 |
Dayco Products, Llc |
Collar for fuel filler pipe
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
EP1575499A2
(en)
|
2002-06-28 |
2005-09-21 |
Centocor, Inc. |
Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
|
WO2004002417A2
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
WO2004009627A1
(en)
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
TW200413406A
(en)
|
2002-08-26 |
2004-08-01 |
Kirin Brewery |
Peptides and drugs containing the same
|
EP2213685B1
(en)
|
2002-09-06 |
2013-11-27 |
Amgen Inc. |
Therapeutic anti-IL-1R1 monoclonal antibody
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
CN100348618C
(zh)
|
2002-09-11 |
2007-11-14 |
弗雷泽纽斯卡比德国有限公司 |
生产羟烷基淀粉衍生物的方法
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
WO2004034988A2
(en)
|
2002-10-16 |
2004-04-29 |
Amgen Inc. |
Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
JP4341239B2
(ja)
|
2002-12-19 |
2009-10-07 |
ニプロ株式会社 |
液体移注具
|
MEP57508A
(en)
|
2002-12-20 |
2011-05-10 |
Amgen Inc |
Binding agents which inhibit myostatin
|
ES2397833T3
(es)
|
2003-03-05 |
2013-03-11 |
Csl Behring Gmbh |
Dispositivo de transferencia
|
CA2518980A1
(en)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
ATE549359T1
(de)
|
2003-04-02 |
2012-03-15 |
Hoffmann La Roche |
Antikörper gegen den insulinähnlichen wachstumsfaktor i-rezeptor und deren verwendungen
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
CA2525464A1
(en)
|
2003-05-12 |
2004-11-25 |
Qun Yin |
Novel poly(ethylene glycol) modified compounds and uses thereof
|
KR101227666B1
(ko)
|
2003-05-12 |
2013-01-31 |
아피맥스, 인크. |
에리스로포이에틴 수용체에 결합하는 펩티드
|
WO2004101606A2
(en)
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
MXPA05012936A
(es)
|
2003-05-30 |
2006-05-17 |
Johnson & Johnson |
Formacion de conjugados novedosos de eritropoietina utilizando transglutaminasa.
|
US20040249235A1
(en)
|
2003-06-03 |
2004-12-09 |
Connell Edward G. |
Hazardous material handling system and method
|
WO2005001136A1
(en)
|
2003-06-04 |
2005-01-06 |
Irm Llc |
Methods and compositions for modulating erythropoietin expression
|
US7579157B2
(en)
|
2003-07-10 |
2009-08-25 |
Hoffmann-La Roche Inc. |
Antibody selection method against IGF-IR
|
NZ544751A
(en)
|
2003-07-15 |
2009-05-31 |
Amgen Inc |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
|
TW201319088A
(zh)
|
2003-07-18 |
2013-05-16 |
Amgen Inc |
對肝細胞生長因子具專一性之結合劑
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
EP1663278A4
(en)
|
2003-08-28 |
2009-07-29 |
Biorexis Pharmaceutical Corp |
EPO MIMETIC PEPTIDES AND FUSION PROTEINS
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
WO2005081687A2
(en)
|
2003-09-30 |
2005-09-09 |
Centocor, Inc. |
Human hinge core mimetibodies, compositions, methods and uses
|
BRPI0416603A
(pt)
|
2003-11-07 |
2007-01-30 |
Immunex Corp |
anticorpo que se liga ao receptor interleucina-4 (il-4) humano
|
AR046639A1
(es)
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20070254834A1
(en)
|
2003-11-24 |
2007-11-01 |
Defrees Shawn |
Glycopegylated Erythropoietin
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
EP1548031A1
(en)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Nature-identical erythropoietin
|
KR20060124656A
(ko)
|
2003-12-31 |
2006-12-05 |
메르크 파텐트 게엠베하 |
개선된 약물동태를 가지는 Fc-에리스로포이에틴 융합단백질
|
AU2004311796A1
(en)
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Novel recombinant proteins with N-terminal free thiol
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
WO2005070451A1
(en)
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Pharmaceutical composition comprising non-glycosylated erythropoietin
|
DE102004005435B3
(de)
|
2004-02-04 |
2005-09-15 |
Haindl, Hans, Dr. |
Medizinisches Transfergerät
|
WO2005084711A1
(fr)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
Erythropoietine recombinante pegylee a activite in vivo
|
TW200603818A
(en)
|
2004-03-11 |
2006-02-01 |
Fresenius Kabi De Gmbh |
Conjugates of hydroxyethyl starch and erythropoietin
|
IL160891A0
(en)
|
2004-03-16 |
2004-08-31 |
|
Auto-mix needle
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
JP2008508854A
(ja)
|
2004-04-23 |
2008-03-27 |
ケンブリッジ アンティボディー テクノロジー リミテッド |
エリスロポイエチンタンパク質変異体
|
US20050248098A1
(en)
*
|
2004-04-27 |
2005-11-10 |
Sisk David E |
Gasket for a coupler upon a rail car, tank trailer, or related means
|
ES2325034T3
(es)
|
2004-07-07 |
2009-08-24 |
H. Lundbeck A/S |
Nueva epo carbamilada y metodo para su produccion.
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
WO2006029094A2
(en)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
CA2586915A1
(en)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules which promote hematopoiesis
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
AU2006208226A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
US20070060904A1
(en)
|
2005-03-14 |
2007-03-15 |
Becton, Dickinson And Company |
Filling system and method for syringes with short needles
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
US7648491B2
(en)
|
2005-05-13 |
2010-01-19 |
Bob Rogers |
Medical substance transfer system
|
PT2100618E
(pt)
|
2005-06-17 |
2014-04-07 |
Philadelphia Health & Educatio |
Um anticorpo anti-pdgfr-alfa para o tratamento de cancro ósseo metastático
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
EP2397496A3
(en)
|
2005-07-18 |
2013-05-29 |
Amgen, Inc |
Human anti-B7RP1 neutralizing antibodies
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
US7804405B2
(en)
*
|
2005-09-09 |
2010-09-28 |
B&G International, Inc. |
Tamper-evident bottle overcap for supporting an electronic tag
|
US7547300B2
(en)
|
2006-04-12 |
2009-06-16 |
Icu Medical, Inc. |
Vial adaptor for regulating pressure
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
CA2652578A1
(en)
|
2006-05-19 |
2007-11-29 |
Glycofi, Inc. |
Erythropoietin compositions
|
US7473246B2
(en)
|
2006-06-22 |
2009-01-06 |
Baxter International Inc. |
Medicant reconstitution container and system
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
EP2121083A2
(en)
|
2007-02-01 |
2009-11-25 |
PA Knowledge Limited |
Auto injector and adaptor for covering the needle of the auto injector
|
WO2008144575A2
(en)
|
2007-05-18 |
2008-11-27 |
Optiscan Biomedical Corporation |
Fluid injection and safety system
|
US8091727B2
(en)
*
|
2007-11-08 |
2012-01-10 |
Hospira, Inc. |
Snap-over clamshell protective port cap
|
US8466793B2
(en)
*
|
2008-10-03 |
2013-06-18 |
B&G Plastics, Inc. |
Electronic tag holder for bottle neck
|
US8228200B2
(en)
*
|
2008-10-03 |
2012-07-24 |
B&G Plastics, Inc. |
Electronic tag holder for bottle neck
|
US20100089494A1
(en)
|
2008-10-14 |
2010-04-15 |
Pam Brady |
Container coupler
|
US8432286B2
(en)
*
|
2008-12-03 |
2013-04-30 |
B&G International, Inc. |
Electronic tag holder for capped bottle neck
|
WO2010096061A1
(en)
*
|
2009-02-23 |
2010-08-26 |
Animal Innovations, Inc. |
Intelligent sleeve container for use in a controlled syringe system
|
US9345640B2
(en)
|
2009-04-14 |
2016-05-24 |
Yukon Medical, Llc |
Fluid transfer device
|
US8425487B2
(en)
|
2009-07-01 |
2013-04-23 |
Fresenius Medical Care Holdings, Inc. |
Drug vial spikes, fluid line sets, and related systems
|
BR112012025821A2
(pt)
*
|
2010-04-09 |
2016-06-28 |
Sanofi Aventis Deutschland |
elemento de conexão de reservatório de fármaco codificado com flange articulado
|
EP3338834B1
(en)
*
|
2010-08-13 |
2022-06-08 |
Sanofi-Aventis Deutschland GmbH |
Coded drug reservoir connection element with hinge
|